Jump Financial, LLC Iovance Biotherapeutics, Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	SELL	$4.44 - $8.79 $71,452 - $141,457	-16,093 Reduced 37.93%	26,337 $119,000
Q3 2023 Nov 07, 2023	SELL	$4.44 - $8.79 $71,452 - $141,457	-16,093 Reduced 37.93%	26,337 $119,000
Q2 2023 Oct 21, 2024	BUY	$5.36 - $9.06 $168,320 - $284,511	31,403 Added 284.78%	42,430 $298,000
Q2 2023 Aug 07, 2023	BUY	$5.36 - $9.06 $168,320 - $284,511	31,403 Added 284.78%	42,430 $298,000
Q1 2023 Oct 21, 2024	BUY	$5.53 - $8.22 $60,979 - $90,641	11,027 New	11,027 $67,000
Q1 2023 May 03, 2023	SELL	$5.53 - $8.22 $531,167 - $789,547	-96,052 Reduced 89.7%	11,027 $67,000
Q4 2022 Feb 13, 2023	SELL	$5.62 - $10.0 $93,095 - $165,650	-16,565 Reduced 13.4%	107,079 $684,000
Q3 2022 Nov 07, 2022	BUY	$9.53 - $13.11 $1.18 Million - $1.62 Million	123,644 New	123,644 $1.19 Million

319

239M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $945M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.